Finacea Receives FDA Approval for Treating Rosacea
The U.S. FDA recently approved Finacea to treat rosacea. This topical foam or gel is specifically beneficial at treating the pustules and facial redness associated with the common skin disease. Here’s what you need to know about Finacea and rosacea.
In a 12-week trial of over 1,300 rosacea patients, Finacea proved extremely effective for patients who showed both redness and pustules. There were a few side effects that the test subjects experienced, most commonly pain and itching, but generally the topical medication for rosacea was well received. The rosacea medicine becomes available in September 2015.
What is Rosacea?
Rosacea is a common and chronic skin disease that causes intense redness, some pimples, and even bulbous growths on the nose. In addition, rosacea can spread to the eyes (ocular rosacea) causing itchiness, styes, and redness. Left untreated, rosacea itself is not dangerous, but ocular rosacea can damage the cornea in rare cases, potentially leading to blindness.
How Finacea Works
Finacea by Bayer Healthcare is a topical foam or gel treatment containing a 15 percent solution of azelaic acid. Azelaic acid, a natural compound found in grains like wheat and barley, both kills bacteria linked to acne and rosacea, reduces the growth of keratin that promotes acne, and helps the skin affected by rosacea grow healthy new cells more rapidly.
If you want to learn more about Finacea for rosacea, sign up for the Rosacea Concierge program at Bayer Healthcare. Membership is free, and members save $30 on Finacea rosacea medication.